Centermed krakow sp zoo

Krakow 31-530

0 studies enrolling now · 5 studies all time

What they study most

Alopecia Areata, Atopic Dermatitis, Osteoarthritis, Osteogenesis Imperfecta

Studies at this site

• A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) — Completed
• Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta — Running, not enrolling
• Long-Term PF-06651600 for the Treatment of Alopecia Areata — Completed
• Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee — Completed
• PF-06651600 for the Treatment of Alopecia Areata — Completed